Aurobindo Pharma

History

YearDetail
1986 Established Aurobindo Pharma Limited (APL).
1988 - 1989 Commenced manufacturing semi synthetic penicillins.
1992 - 1993 Started another unit was established for the manufacture of CMIC Chloride.
1994 - 1995 Merged with Chaitanya Organics Pvt. Ltd. 
1997 - 1998 Formed an alliance with Glaxo (India) the Indian.
1999 - 2000 Sri Chakra Remedies Ltd was amalgamated with Aurobindo Pharma Limited.
2001 - 2002 Acquired 79% stake in Ranit Pharma Co.
2003 - 2004 Joint Venture between APL and Shanxi Tongling Pharmaceuticals launched.
2004 - 2005 Received US FDA clearance for AIDS drugs.
2005 - 2006 Aurobindo made a strategic entry into the premium markets of U.S. and Europe.
2007 - 2008 Acquired intellectual property and marketing authorizations with TAD Italy.
2014 - 2016 Acquired certain commercial operations in Western Europe from Actavis Plc.
2017 - 2018 Acquired Generis in Portugal.
2019 - 2020 Started setting up an oral solid manufacturing facility at Taizhou for China.
2021 Acquired 9 OTC brands.